National Institute of Allergy & Infectious Diseases: Ebola Vaccine Regimens Safe, Immunogenic In Adults And Children
December 14, 2022
December 14, 2022
WASHINGTON, Dec. 14 (TNSjou) -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release on Dec. 14, 2022:
* * *
NIAID Participated in International PREVAC Consortium
* * *
Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according . . .
* * *
NIAID Participated in International PREVAC Consortium
* * *
Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according . . .